Notable Labs, Ltd. (NTBLQ)

Market Cap	202.85K
Revenue (ttm)	313.00K
Net Income (ttm)	-10.54M
Shares Out	9.66M
EPS (ttm)	-1.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.0210
Previous Close	0.0250
Day's Range	0.0210 - 0.0210
52-Week Range	0.0100 - 2.7000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Notable Labs

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company’s pipeline includes...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: NTBLQ

Financial Performance

In 2023, Notable Labs's revenue was $310,000, an increase of 3775.00% compared to the previous year's $8,000. Losses were -$11.26 million, -21.82% less than in 2022.